CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Frank Steven Director | Grant or award | +1,288 | $9.70 | $12K | 36,747 |
| 2026-06-11 | Frank Steven Director | Grant or award | +15,294 | 35,459 | ||
| 2026-06-11 | Frank Steven Director | Grant or award · Automatic Stock Option Grant | +33,540 | 33,540 | ||
| 2026-05-29 | Frank Steven Director | Grant or award | +1,262 | $8.91 | $11K | 20,165 |
| 2026-02-27 | Frank Steven Director | Grant or award | +1,285 | $8.75 | $11K | 18,903 |
| 2025-11-28 | Frank Steven Director | Grant or award | +1,566 | $7.18 | $11K | 17,618 |
| 2025-08-29 | Frank Steven Director | Grant or award | +1,353 | $8.31 | $11K | 16,052 |
| 2025-06-12 | Frank Steven Director | Grant or award | +12,500 | 14,699 | ||
| 2025-06-12 | Frank Steven Director | Grant or award · Automatic Stock Option Grant | +27,181 | 27,181 | ||
| 2025-05-30 | Frank Steven Director | Grant or award | +333 | $10.75 | $4K | 2,199 |
| 2025-05-02 | Frank Steven Director | Grant or award | +1,866 | 1,866 | ||
| 2025-05-02 | Frank Steven Director | Grant or award · Automatic Stock Option Grant | +4,079 | 4,079 |
Page 1 of 1 · 12 trades